1
|
Variation intra-individuelle de l’hémoglobine chez les patients drépanocytaires à l’état stable. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.10.108] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
2
|
Fertilité chez les patients atteints de fièvre méditerranéenne familiale (FMF) : étude au sein d’une population de 331 patients. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.360] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
3
|
La transition de la pédiatrie à l’âge adulte dans les maladies auto-inflammatoires : l’expérience d’un centre de référence adulte sur 72 patients. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.357] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
4
|
Pneumopathies interstitielles kystiques chez des patients drépanocytaires : une série de 11 cas. Rev Mal Respir 2018. [DOI: 10.1016/j.rmr.2017.10.071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
5
|
L’obésité est-elle une cause émergente d’amylose AA ? À propos d’une cohorte française de 12 patients. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.347] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
6
|
Maladies inflammatoires chroniques de l’intestin chez des patients atteints de syndrome drépanocytaire majeur : à propos de 6 cas. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
7
|
Connaissance et prise en charge de la fièvre méditerranéenne familiale en ville : enquête auprès de 32 médecins généralistes. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.333] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
8
|
Le syndrome d’hyperémèse cannabinoïde : un diagnostic différentiel de la fièvre méditerranéenne familiale : à propos de 7 cas. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
9
|
Le syndrome PFAPA (ou syndrome de Marshall) existe-t-il chez les adultes ? À propos de 20 cas. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
10
|
Les fièvres héréditaires périodiques associées à des mutations de NLRP12 : revue systématique de la littérature. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.053] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
11
|
Amylose AA secondaire à la fièvre méditerranéenne familiale : à propos de 38 cas. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.101] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
12
|
Cytolyse au cours de la fièvre méditerranéenne familiale : étude prospective chez 19 adultes. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
13
|
Amylose AA au cours du déficit en mévalonate kinase : à propos de 14 cas. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
14
|
Maladies auto-immunes au cours des syndromes drépanocytaires majeurs : étude de 26 cas. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.04.314] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
15
|
Les maladies autoinflammatoires inclassées existent-t- elles? A propos de 56 cas adultes. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.04.287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
16
|
Abstract
Sickle cell disease is a systemic genetic disorder, causing many functional and tissular modifications. As the prevalence of patients with sickle cell disease increases gradually in France, every physician can be potentially involved in the care of these patients. Complications of sickle cell disease can be acute and chronic. Pain is the main symptom and should be treated quickly and aggressively. In order to reduce the fatality rate associated with acute chest syndrome, it must be detected and treated early. Chronic complications are one of the main concerns in adults and should be identified as early as possible in order to prevent end organ damage. Many organs can be involved, including bones, kidneys, eyes, lungs, etc. The indications for a specific treatment (blood transfusion or hydroxyurea) should be regularly discussed. Coordinated health care should be carefully organized to allow a regular follow-up near the living place and access to specialized departments. We present in this article the French guidelines for the sickle cell disease management in adulthood.
Collapse
|
17
|
Syndrome de la houppe mentonnière chez patients drépanocytaires : étude de 35 cas. Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.10.331] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
18
|
Survenue d’une paralysie faciale chez des patients drépanocytaires : étude de 8 cas. Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.10.330] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
19
|
Vascularites associées à la fièvre méditerranéenne familiale : étude de 17 cas. Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.10.252] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
20
|
“Daily life of CAPS patients treated with canakinumab (Ilaris®) : data from the French observational study - ENVOL Study”. Pediatr Rheumatol Online J 2015. [PMCID: PMC4600039 DOI: 10.1186/1546-0096-13-s1-p162] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/04/2022] Open
|
21
|
Hyperphosphatémie chez les patients drépanocytaires homozygotes : une hyperréabsorption primitive du tube contourné proximal et un marqueur de risque cardiovasculaire. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.10.044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
22
|
Histoire naturelle de la néphropathie drépanocytaire : étude d’une cohorte monocentrique de jeunes adultes homozygotes suivis pendant 5ans. Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.10.103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
23
|
Résultats préliminaires de l’étude clinique prospective RAND : étude des relations cœur-reins–microcirculation dans une population de patients drépanocytaires homozygotes hyperfiltrants albuminuriques. Nephrol Ther 2013. [DOI: 10.1016/j.nephro.2013.07.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
24
|
Drépanocytose et complications du voyage : étude de 148 adultes. Rev Med Interne 2009. [DOI: 10.1016/j.revmed.2009.10.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
25
|
|
26
|
Abstract
Sickle cell disease is a systemic disease that can potentially involve all organs. As the prevalence of patients with sickle cell disease increases gradually in France, every physician can be potentially involved in the care of these patients. Complications of sickle cell disease can be acute or chronic. Pain is the main symptom and should be treated quickly and aggressively. Acute chest syndrome is the leading cause of acute death and must be prevented, detected, and treated without delay. Chronic complications are one of the main concerns in adults and should be identified as early as possible in order to prevent sequels. Many organs can be involved, including the bones, kidneys, eyes, lungs... The indications for a specific treatment (blood transfusion or hydroxyurea) should be discussed. Health care should be carefully organized to allow both a regular follow-up near the living place and access to specialized departments. We present in this article the French guidelines for the sickle cell disease management in adulthood.
Collapse
|
27
|
Quoi de neuf dans les maladies auto-inflammatoires ? Rev Med Interne 2008; 29:994-9. [DOI: 10.1016/j.revmed.2008.01.022] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2007] [Revised: 01/03/2008] [Accepted: 01/13/2008] [Indexed: 11/30/2022]
|
28
|
Prévalence de l’hyperfiltration glomérulaire chez les patients drépanocytaires homozygotes. Rev Med Interne 2008. [DOI: 10.1016/j.revmed.2008.10.090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
29
|
|
30
|
Kawasaki-like syndromes in HIV-infected adults. J Infect 2007; 55:488-94. [PMID: 17953991 DOI: 10.1016/j.jinf.2007.09.005] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2007] [Revised: 09/06/2007] [Accepted: 09/08/2007] [Indexed: 11/28/2022]
Abstract
BACKGROUND Kawasaki-like syndrome (KLS) is rare in adults; one third of these patients are infected by Human immunodeficiency virus (HIV). Our study reports cases of KLS occurring in HIV-positive adults and reviews the literature to compare their characteristics with HIV-negative adults and children with Kawasaki disease (KD). METHODS Report of cases and review of the literature. RESULTS Amongst 20 cases reviewed, including 4 who were managed at our institution, KLS was associated with severe immunosuppression and a high HIV viral load. There was frequent co-infection by hepatitis viruses. Desquamation and liver abnormalities were more frequent in HIV-negative adults whereas headaches and gastrointestinal disorders more common in HIV-positive adults. Intravenous immunoglobulin was effective therapy. Relapse was more frequent among HIV-positive patients. No cardiovascular complications or deaths occurred. CONCLUSIONS Advanced immunosuppression due to HIV may predispose to KLS. The differential diagnosis that must be considered includes drug hypersensitivity reactions and staphylococcal infections.
Collapse
|
31
|
Evidence for CTL-mediated selection of Tat and Rev mutants after the onset of the asymptomatic period during HIV type 1 infection. AIDS Res Hum Retroviruses 2006; 22:1283-92. [PMID: 17209772 DOI: 10.1089/aid.2006.22.1283] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
The evolution of HIV-1 sequences over time is the result of the selection of mutant variants that have escaped from host immune responses or the outgrowth of mutants with increased viral replication, or both. We investigated the contribution of both selection processes to the overall evolution of the Tat and Rev regulatory gene sequences from four individuals, ranging in time from just prior to seroconversion to stable asymptomatic infection. After sequencing at least 15 clones per sample per gene, we analyzed the sequence evolution of the MHC-I motifs that were predicted from the MHC-I haplotypes of these patients. For each identified Tat sequence, we tested the activity of the corresponding encoded protein in a transactivation assay in vitro. Our results suggest that the evolution of the Tat and Rev sequences from these individuals can be explained by mutational escape of the MHC-I epitopes and that no mutations that replaced the original sequences in the viral population are associated with either an increase or decrease in Tat activity. CTL-mediated selection appears to be an important determinant of HIV-1 regulatory gene sequence evolution during the early stages of infection.
Collapse
MESH Headings
- Amino Acid Sequence
- Epitopes
- Evolution, Molecular
- Gene Products, rev/genetics
- Gene Products, rev/immunology
- Gene Products, tat/genetics
- Gene Products, tat/immunology
- Genes, rev/genetics
- Genes, rev/immunology
- Genes, tat/immunology
- HIV Infections/genetics
- HIV Seropositivity/genetics
- HIV Seropositivity/virology
- HIV-1/genetics
- Humans
- Molecular Sequence Data
- Selection, Genetic
- Sequence Alignment
- T-Lymphocytes, Cytotoxic/virology
- Virus Replication
- rev Gene Products, Human Immunodeficiency Virus
- tat Gene Products, Human Immunodeficiency Virus
Collapse
|
32
|
Maladie de Kawasaki et VIH: analyse de cinq cas et revue de la littérature. Rev Med Interne 2006. [DOI: 10.1016/j.revmed.2006.10.067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
33
|
Sclérodermie paranéoplasique et adénocarcinome gastrique. Rev Med Interne 2006. [DOI: 10.1016/j.revmed.2006.10.188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
34
|
Aspergilloses au cours de maladies systémiques traitées par corticoïdes et/ou immunosuppresseurs : analyse de neuf cas et revue de la littérature. Rev Med Interne 2006; 27:813-27. [PMID: 16982117 DOI: 10.1016/j.revmed.2006.07.007] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2006] [Accepted: 07/12/2006] [Indexed: 11/24/2022]
Abstract
This is a multicentric retrospective study of aspergillosis in patients treated by corticosteroids and/or immunosuppressive drugs for systemic diseases and a review of the literature. Nine patients, 5 men and 4 women, mean age of 62.8 years old were included among which Horton's diseases (3 cases), systemic lupus erythematosus (2), polymyositis (1), microscopic polyangiitis (1), idiopathic thrombocytopenic purpura (1), rheumatoid polyarthritis (1). Aspergillosis occurred in average 28.4 month after the diagnosis of systemic disease, and 28 months after the beginning of its treatment: corticosteroids in all cases, at a dose of 50.8 mg/day (equivalent prednisone) in average, cyclophosphamide (2 cases), methotrexate (1), intravenous immunoglobulins (1), leflunomide (1). All cases were invasive or chronic pulmonary aspergillosis located in the lungs (6 cases), or in the brain (3). Revealing symptoms were mild and non specific. Lymphopenia was severe in most cases, in average 472 lymphocytes/mm3 and 283 CD4+/mm3. The diagnosis was confirmed 20.75 days after the first symptoms in invasive aspergillosis, and 18.5 months in the chronic pulmonary cases, by cultures in 7 cases (broncho-alveolar lavage: 4; cerebral biopsy: 3), and direct microscopy examination of broncho-alveolar lavage in 2 cases. Specific serology was positive in 4 cases. Patients were treated by voriconazole (4 cases), itraconazole (2), amphotericin B (1), association of caspofungin and voriconazole (1), successive voriconazole and itraconazole (1). Six patients recovered from aspergillosis with 10.8 months of following time, 3 patients died a few days after confirmation of the diagnosis. Fifty-four cases of the literature are analysed.
Collapse
MESH Headings
- Adrenal Cortex Hormones/therapeutic use
- Adult
- Aged
- Aged, 80 and over
- Arthritis, Rheumatoid/complications
- Arthritis, Rheumatoid/drug therapy
- Aspergillosis/complications
- Aspergillosis/diagnosis
- Aspergillosis/drug therapy
- Aspergillosis/mortality
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Giant Cell Arteritis/complications
- Giant Cell Arteritis/drug therapy
- Humans
- Immunosuppressive Agents/therapeutic use
- Lupus Erythematosus, Systemic/complications
- Lupus Erythematosus, Systemic/drug therapy
- Male
- Middle Aged
- Polymyositis/complications
- Polymyositis/drug therapy
- Purpura, Thrombocytopenic, Idiopathic/complications
- Purpura, Thrombocytopenic, Idiopathic/drug therapy
- Retrospective Studies
Collapse
|
35
|
|
36
|
Abstract
PURPOSE Carcinoma of unknown primary site is a common clinical syndrome, accounting for 2% of cancer patients. Diagnosis is a recurrent challenge for internists. Treatment is difficult and prognosis is still poor. This review presents one synthesis of diagnosis strategies and therapeutic trials. It envisages the interest of new molecular biology methods as well as therapeutic perspectives. CURRENT KNOWLEDGE AND KEY POINTS Pathologic examination completed with immunohistochemical tests, and, depending on cases, with electron microscopy, cytogenetics, and molecular biology is a key-point for diagnosis. Diagnosis work-up, based on histological type and on individualization of some clinical presentation, proceeds in three steps. Positron emission tomography is recommended when a curative treatment is planed, particularly in cases of isolated metastasis. Functional status analysed using the performance status and simple biologic parameters (serum lactate dehydrogenase, serum alkaline phosphatase) permit us to assess prognosis. Chemotherapy is offered for patients with a good general health status. FUTURE PROSPECTS AND PROJECTS Further evaluation of positron emission tomography, as well as cost-benefit analyses, is warranted. Further randomised trials are necessary to determine the optimal chemotherapy regimen in good-risk patients and the interest of chemotherapy in patients with poor-risk disease. Gene expression profiling and proteomic evaluation, as well as pharmacogenomic offer new investigation fields.
Collapse
|
37
|
[Lemierre syndrome variant: Hepatic abscesses and hepatic venous thrombosis due to Fusobacterium nucleatum septicemia]. Rev Med Interne 2006; 27:482-6. [PMID: 16516355 DOI: 10.1016/j.revmed.2005.12.013] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2005] [Accepted: 12/14/2005] [Indexed: 10/25/2022]
Abstract
INTRODUCTION Like Fusobacterium necrophorum, Fusobacterium nucleatum is capable causing Lemierre's syndrome. Various locations of venous thrombosis have been described associated with Fusobacterium sp. septicemia. EXEGESIS We describe a 43-year old alcoholic patient with F.nucleatum septicemia complicated with hepatic abscesses, middle hepatic venous thrombosis, osteomyelitis and infiltrative pneumonia. A pancreatic prosthesis was the only potentially identified infectious entrance. CONCLUSION Our patient showed an alternative presentation of Lemierre's syndrome, a "digestive variant". To the best of our knowledge, this is the first report of Fusobacterium septicemia associated with hepatic venous thrombosis. This report is close to the cases of portal thrombosis and opens the clinical sphere of the lemierre's syndrome, whose incidence is increasing.
Collapse
|
38
|
[Look at what is closest...]. Rev Med Interne 2005; 26 Suppl 2:S240-1. [PMID: 16129157 DOI: 10.1016/s0248-8663(05)80037-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
39
|
Abstract
Vasculitis associated with anti-neutrophil cytoplasmic antibodies has been reported in patients treated with anti-thyroid drugs and especially propylthiouracil. We report here a case of granulomatous eosinophilic vasculitis mimicking gastric neoplasm and peripheral eosinophilia in a 27-year-old man who was treated with carbimazole for 5 months for Graves' disease. Clinical and morphologic features resolved within 2 months after stopping the drug, suggesting a causative role for the drug. To our knowledge, this is the first biopsy-proven granulomatous eosinophilic vasculitis associated with this drug.
Collapse
|
40
|
Une cigale (américaine) et ses fourmis…. Rev Med Interne 2005; 26 Suppl 2:S277-8. [PMID: 16129173 DOI: 10.1016/s0248-8663(05)81283-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
41
|
[An aortic abnormality]. Rev Med Interne 2005; 27:66-7. [PMID: 15923064 DOI: 10.1016/j.revmed.2005.04.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2005] [Accepted: 04/11/2005] [Indexed: 10/25/2022]
|
42
|
[Very severe pregnancy hemolysis...]. Rev Med Interne 2004; 25 Suppl 2:S290-1. [PMID: 15460484 DOI: 10.1016/s0248-8663(04)80037-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
43
|
Mastocytose systémique : Une présentation initiale souvent trompeuse. Rev Med Interne 2002. [DOI: 10.1016/s0248-8663(02)80492-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
44
|
Glycogénose 1 b et maladie inflammatoire de l'intestin. Rev Med Interne 2002. [DOI: 10.1016/s0248-8663(02)80680-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|